[Antidiarrheal drugs for chronic diarrhea]
1Medizinische Klinik I, St. Marienkrankenhaus Ludwigshafen.
Deutsche Medizinische Wochenschrift (1946)
|October 29, 2013
Summary
Chronic diarrhea has many causes requiring diagnosis for targeted treatment. Symptomatic management with medications like loperamide or probiotics can prevent fluid loss and be used long-term.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Context:
- Chronic diarrhea presents a diagnostic challenge due to diverse underlying etiologies.
- Effective management necessitates differentiating between specific treatable conditions and those requiring symptomatic relief.
Purpose:
- To outline diagnostic approaches for chronic diarrhea.
- To review symptomatic treatment options for chronic diarrhea when specific therapies are not feasible.
Summary:
- Basic diagnostic tests are crucial for identifying specific causes of chronic diarrhea.
- Symptomatic treatments including loperamide, cholestyramine, bulking agents, probiotics, anticholinergic agents, and opioids can manage fluid and electrolyte losses.
- These agents, when used appropriately, offer long-term efficacy with a favorable side effect profile.
Impact:
- Provides a framework for managing chronic diarrhea, aiming to prevent complications like dehydration and electrolyte imbalance.
- Highlights the importance of tailored therapeutic strategies, balancing specific treatments with symptomatic relief.
- Supports clinicians in selecting appropriate long-term medications for chronic diarrhea management.
Related Concept Videos
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
864
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
864
01:17Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
603
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
603
01:21Drugs for Treatment of Constipation-Predominant IBS
1.5K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.5K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721